RSPO1 and colorectal carcinoma: [13] detected for the first time an R-spondin fusion protein in early-onset CRC organoids, which had been previously reported only in cell lines, a finding beneficial for the clinical application of Wnt secretion inhibitors or anti-RSPO mAb.